Guggenheim Capital’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-10,124
| Closed | -$30K | – | 3063 |
|
|
2016
Q3 | $30K | Buy |
+10,124
| New | +$30K | ﹤0.01% | 2791 |
|
|
2015
Q3 | – | Sell |
-189,734
| Closed | -$3.6M | – | 3076 |
|
|
2015
Q2 | $3.6M | Sell |
189,734
-154,977
| -45% | -$2.94M | 0.01% | 1334 |
|
|
2015
Q1 | $9.02M | Buy |
344,711
+222,633
| +182% | +$5.83M | 0.02% | 897 |
|
|
2014
Q4 | $2.56M | Buy |
122,078
+30,797
| +34% | +$645K | 0.01% | 1541 |
|
|
2014
Q3 | $3.05M | Buy |
91,281
+2,144
| +2% | +$71.6K | 0.01% | 1453 |
|
|
2014
Q2 | $2.86M | Sell |
89,137
-3,776
| -4% | -$121K | 0.01% | 1500 |
|
|
2014
Q1 | $4.29M | Buy |
92,913
+22,826
| +33% | +$1.05M | 0.01% | 1206 |
|
|
2013
Q4 | $4.97M | Buy |
70,087
+9,127
| +15% | +$648K | 0.02% | 1087 |
|
|
2013
Q3 | $5.23M | Buy |
60,960
+7,298
| +14% | +$626K | 0.02% | 1063 |
|
|
2013
Q2 | $3.4M | Buy |
+53,662
| New | +$3.4M | 0.01% | 1220 |
|